– USA, CA – Vitalacy, Inc. today announced the appointment of Ron Whitfield to its Board of Directors, bringing a wealth of experience and connections to global technology companies in segments of Cloud, Telco, Enterprise, and SaaS through a successful career in business development, sales, and strategy.
About Ron Whitfield
Ron Whitfield worked at Intel Corporation for 20 years in roles of Global Director of Market Development & Director of Sales. He has been an entrepreneur for 10 years and held several leadership positions with verticals to healthcare care management. Over 2 years ago he formed the first business development program for Intel Ignite, a startup accelerator with offices in Tel Aviv, Munich, and Boston. Whitfield assists founders and management teams in forming strategic partnerships to scale business and set up several of those relationships leading to successful strategic partnership agreements and also an exit.
Ron Whitfield said: “Vitalacy has an impressive and unique suite of products with a team motivated to help others while having a clear path to business growth. I’m energized by their development pipeline to improve more spheres of patient outcomes and deliver hospitals and patient care organizations reduced costs and improved patient outcomes. I see so much potential in their technology.”
About Vitalacy
Vitalacy is a patient safety technology company based in Los Angeles, Calif., partnering with hospitals to fight against healthcare-acquired conditions. Automated technology solutions improve patient outcomes, protect the workforce, and promote quality and safety measures that save lives. By gathering hand hygiene compliance data in real-time, the company gives hospitals an accurate and comprehensive picture of baseline performance, as well as the tools to improve performance and reduce infections.
SOURCE: Vitalacy
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.
